Smith+Nephew Bolsters Shoulder Repair Portfolio with Integrity Orthopaedics Buy
Event summary
- Smith+Nephew completed the acquisition of Integrity Orthopaedics on January 21, 2026.
- Integrity Orthopaedics' Tendon Seam™ system is designed to reduce re-tear rates and improve patient outcomes in rotator cuff repair (RCR).
- Tendon Seam™ received 510(k) clearance in 2023 and is indicated for reattachment of soft tissue to bone.
- The acquisition strengthens Smith+Nephew's sports medicine shoulder repair business, complementing its REGENETEN Bioinductive Implant.
The big picture
Smith+Nephew's acquisition of Integrity Orthopaedics solidifies its position in the shoulder repair market, addressing high structural failure rates in traditional surgical techniques. The deal complements Smith+Nephew's existing REGENETEN Bioinductive Implant, creating a unique portfolio that combines biomechanical repair and biological augmentation. This strategic move comes as the RCR market continues to grow, with approximately 500,000 procedures performed annually in the US.
What we're watching
- Market Penetration
- How Smith+Nephew will leverage its commercial channels to accelerate adoption of Tendon Seam™ in the US.
- Global Expansion
- The pace at which Smith+Nephew builds evidence to support global adoption of Tendon Seam™.
- Competitive Advantage
- Whether Smith+Nephew can sustain its differentiated portfolio in the growing RCR market.
Related topics